Chief executive
Albert Bourla
Chairman & CEO · Pfizer Inc
1 disclosed trade · 12 Aug 2026 to 12 Aug 2026 · latest filed 12 Aug 2026
Chief executive of Pfizer Inc (PFE), tracked from the executive's own SEC Form 4 disclosures.
Net buying by company
| Company | Share of net buying | Est. net |
|---|---|---|
| Common Stock (PFE) | 100.0% | $1.0M |
Recent disclosed trades
| Company | Trade date | Action | Amount |
|---|---|---|---|
| Common Stock (PFE) | 2026-08-12 | Buy | $1,000,920 |
Source: SEC Form 4 filings, trades from 12 Aug 2026 to 12 Aug 2026, latest filed 12 Aug 2026. Executives report their own trades on Form 4 within two business days.
Open the interactive profile: all trades, compare with others